Astrazeneca reported $1.64B in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
AstraZeneca AZN:LN USD 1.64B 1.28B
Astrazeneca AZN:US USD 1.64B 1.28B
Bristol Myers Squibb BMY:US USD 1.61B 185M
Canopy Growth Corp WEED:CN CAD -221806000 1.86B
Corcept Therapeutics CORT:US USD 34.61M 7.2M
Eli Lilly And LLY:US USD 1.45B 499.2M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Genmab GEN:DC DKK 2.58B 691M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Horizon Pharma HZNP:US USD 135.84M 74.86M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Johnson & Johnson JNJ:US USD 4.46B 356M
Lannett LCI:US USD -28019000 65.28M
Merk MRK:US USD 3.25B 696M
Novartis NOVN:VX USD 1.57B 121M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Pfizer PFE:US USD 8.61B 1.3B
Prestige Brands PBH:US USD 51.02M 4.25M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
Valeant Pharmaceuticals VRX:CN USD 399M 544M
Zoetis ZTS:US USD 529M 0